Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder

Clinical Chemistry

Volumn 43, Issue 3, 1997, Pages 541-543

  Nygaard, Øystein ^a   Langbakk, Bodil ^a   Romner, Bertil ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

ADULT; AGED; AGING; ARTICLE; BRAIN INFARCTION; CELL DAMAGE; CEREBROSPINAL FLUID ANALYSIS; CERVICOBRACHIAL NEURALGIA; ENCEPHALITIS; FEMALE; GLIOBLASTOMA; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALE; MENINGITIS; POLYNEUROPATHY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; REFERENCE VALUE; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE;

EID: 0031043258     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.3.541     Document Type: Article

References (14)

1. Fagnart OC, Sindic CMJ, Laterre C. Particle counting immunoassay of S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988;34:1387-91.
2. Michetti F, Massaro A, Russo G, Rigon G. The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the central nervous system. J Neural Sci 1980;44:259-63.
3. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke 1991;22:1254-8.
4. Kato K, Nakajima T, Ishiguro Y, Matsutani. Sensitive enzyme immunoassay for S-100 protein: determination in human cerebrospinal fluid. Biomed Res 1982;3:24-8.
5. Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983;60:443-51.
6. Persson L, Hårdemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Påhlman S. S-100 protein and neuron-specific-enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous tissue. Stroke 1987;18:911-8.
7. Lamers KJB, van Engelen BGM, Gabreels FJM, Hommes OR, Borm GF, Wevers RA. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders. Acta Neurol Scand 1995;92:247-51.
8. Sindic CJM, Chalon MP, Cambiaso CL, Laterre EC, Masson PL. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982;45:1130-5.
9. van Engelen BGM, Lamers KJB, Gabreels FJM, Wevers RA, van Geel WJA, Borm GF. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem 1992;38:813-6.
10. Henriksson L, Voigt K. Age-dependent difference of distribution and clearance patterns in normal RIHSA cisternograms. Neuroradiology 1976;12: 103-7.
11. Loefberg H, Grubb AO, Sveger T, Olsson JE. The cerebrospinal fluid and plasma concentrations of gamma-trace beta2 microglobulin at various ages and in neurological disorders. J Neurol 1980;223:159-70.
12. Schliep G, Felgenhauer K. Serum-CSF protein gradients, the blood-CSF barrier and the local immune response. J Neurol 1978;218:77-96.
13. Ingebrigtsen T, Romner B, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 1995;59:103-4.
14. Royds JA, Timberly WR, Taylor CB. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change. J Neurol Neurosurg Psychiatry 1981;44:1129-35.